Previous 10 | Next 10 |
Gainers: Camber Energy (NYSEMKT: CEI ) +61% . More news on: Camber Energy, Inc., Cancer Genetics, Inc., Micron Solutions, Inc., Stocks on the move, , Read more ...
Celcuity Inc. (CELC) Q4 2019 Earnings Conference Call March 12, 2020 4:30 P.M. ET Company Participants Brian Sullivan - Chief Executive Officer Vicky Hahne - Chief Financial Officer Conference Call Participants Boobalan - HC Wainwright Per Ostlund - Craig-Hallum Presenta...
Celcuity (NASDAQ: CELC ): Q4 Non-GAAP EPS of -$0.14 beats by $0.04 ; GAAP EPS of -$0.18 beats by $0.01 . Cash and cash equivalents of $18.7M Press Release More news on: Celcuity Inc., Earnings news and commentary, Healthcare stocks news, ,
MINNEAPOLIS, MN / ACCESSWIRE / March 12, 2020 / Celcuity Inc. (NASDAQ:CELC), a functional cellular analysis company that is developing companion diagnostic tests designed to expand the eligible patient populations for targeted therapies, announced financial results for the fourth quarter and...
MINNEAPOLIS, MN / ACCESSWIRE / February 27, 2020 / Celcuity Inc. (NASDAQ:CELC), a functional cellular analysis company that is developing companion diagnostic tests designed to expand the eligible patient populations for targeted therapies, announced that it will release its financial result...
MINNEAPOLIS, MN / ACCESSWIRE / December 11, 2019 / Celcuity Inc. (Nasdaq:CELC), a dynamic cellular analysis company developing diagnostic tests to identify new patient populations for targeted therapies, announced that it presented results from a study of its newly developed CELx PI3K Signal...
Celcuity Inc. (NASDAQ: CELC) a functional cellular analysis company that is discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve clinical outcomes of cancer patients treated with targeted therapies, today announced the appointment of Richard B...
Celcuity Inc. (CELC) Q3 2019 Earnings Conference Call November 07, 2019 4:30 PM ET Company Participants Brian Sullivan - Chief Executive Officer & Co-Founder Vicky Hahne - Chief Financial Officer Conference Call Participants Edward Marks - HC Wainwright Per Ostlund - Cr...
Celcuity (NASDAQ: CELC ): Q3 Non-GAAP EPS of -$0.16 beats by $0.01 ; GAAP EPS of -$0.19 misses by $0.01 . More news on: Celcuity Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Celcuity Inc. (Nasdaq: CELC), a functional cellular analysis company that is discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve clinical outcomes of cancer patients treated with targeted therapies, announced financial results for the third q...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 10:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MINNEAPOLIS, June 03, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies Global Healthcare Conference to be held in New York on June 4-6, 2024. ...
2024-05-30 16:00:09 ET Bradley Canino from Stifel Nicolaus issued a price target of $40.00 for CELC on 2024-05-30 14:29:00. The adjusted price target was set to $40.00. At the time of the announcement, CELC was trading at $15.28. The overall price target consensus is at ...